Cardiac and metabolic effects in patients who present with a multinodular goitre

Netherlands Journal of Medicine

Volumn 61, Issue 10, 2003, Pages 318-322

  Berghout, A ^a   van de Wetering, J ^a   Klootwijk, P ^b  

^a Medisch Centrum Rijnmond Zuid   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FERRITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; THYROTROPIN; TRIACYLGLYCEROL; CHOLESTEROL; THYROID HORMONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTROCARDIOGRAPHY; EUTHYROIDISM; FEMALE; FERRITIN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; LIOTHYRONINE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; METABOLIC DISORDER; NODULAR GOITER; STATISTICAL SIGNIFICANCE; SUPRAVENTRICULAR PREMATURE BEAT; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; HEART ARRHYTHMIA; HYPERTHYROIDISM; IMMUNOASSAY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ARRHYTHMIA; CASE-CONTROL STUDIES; CHOLESTEROL; CREATININE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; GOITER, NODULAR; HEART RATE; HUMANS; HYPERTHYROIDISM; IMMUNOASSAY; MALE; MIDDLE AGED; THYROID HORMONES; THYROTROPIN;

EID: 1442334561     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Henneman G. Nontoxic Goitre. Clin Endocrinol Metab 1979;8:167-79.
2. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol 1977;7;:481-93.
3. Hennemann G. Multinodalar Goiter. In: Groot LJ de, Hennemann G (eds). The Thyroid and its diseases. Chapter 17. 2001. www.thyroidmanager.org.
4. Berghout A, Wiersinga WM, Smits NJ, Touber JL. The interrelationships between age, thyroid volume, thyroid nodularity and thyroid function in patient with sporadic nontoxic goiter. Am J Med 1990;89:602-8.
5. Elte JWF, Bussemaker JK, Haak A. The natural history of euthyroid multinodular goitre. Postgrad Med J 1990;66:186-90.
6. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-52.
7. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001;358:861-5.
8. Biondi B, Fazio S, Carella C, et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1993;77:334-8.
9. Shapiro LE, Sievert R, Ong L, et al. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. J Clin Endocrinol Metab 1997;82:2592-5.
10. Biondi B, Palmieri EA, Fazio F, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000;85:4701-5.
11. Mercuro G, Panzuto MG, Bina A, et al. Cardiac function, physical exercise capacity and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 2000;85:154-64.
12. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol 1992;37: 411-4.
13. Faber J, Perrild H, Johansen JS. Bone gla protein and sex hormone binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level. J Clin Endocrinol Metab 1990;70:49-55.
14. Mudde AH, Bastiaanse AJ, Jonkers H. Is there a relationship between thyroid function and serum osteocalcin in women with multinodular goitre? A preliminary report. Neth J Med 1990;37:17-20.
15. Bell GM, Sawers JSA, Forfar JC, Doig A, Toft AD. The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion. Clin Endocrinol 1983;18:511-6.
16. Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard MC, Gammage MD. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart 1996;75:363-8.
17. Faber J, Wiinberg N, Schifter S, Mehlsen J. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Europ J Endocrinol 2001;145:391-6.
18. Reed Larsen P. Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 1982;306:23-31.
19. Everts ME, Verhoeven FA, Bezstarosti K, et al. Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology 1996;137:4235-42.
20. Croteau W, Davey JC, Galton VA, St Germain DL. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 1996;98:242-3.